Read Our Oncology Update White Paper: Molecular Markers in Solid Tumors
This white paper highlight the recent advances in molecular markers and their application in solid tumors, specifically breast, lung and colorectal cancers.
Continual advances in oncology reinforce the constant promise of more effective and safe diagnostic tools and treatments for patients with cancer, presenting physicians with the challenge of translating these findings into optimization of patient care.
The molecular markers that are currently used to diagnose, treat, and manage patients with breast, lung, or colorectal cancer where covered in this white paper along with the difference between predictive and prognostic markers.


